A carregar...
Publicação
Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 284.63 KB | Adobe PDF |
Orientador(es)
Resumo(s)
We conducted a test-negative case–control study based in five European sentinel surveillance networks. The early 2012/13 adjusted influenza vaccine effectiveness was 78.2% (95% CI: 18.0 to 94.2) against influenza B, 62.1% (95% CI: −22.9 to 88.3%) against A(H1)pdm09, 41.9 (95% CI: −67.1 to 79.8) against A(H3N2) and 50.4% (95% CI: −20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications.
Descrição
Baltazar Nunes: member of the I-MOVE case–control study team
Palavras-chave
Surveillance Influenza Vaccine Estados de Saúde e de Doença Gripe Vacina Cobertura Época 2012/2013
Contexto Educativo
Citação
Euro Surveill. 2013 Feb 14;18(7):3
Editora
ECDC-European Centre for Disease Prevention and Control